Navigation Links
Fate Therapeutics Named One of the 50 Most Innovative Companies in the World by MIT's Technology Review
Date:2/26/2010

and work.

"We are honored to be selected and recognized for our efforts in advancing important discoveries in stem cell biology to create new and better medicines for patients in need," said Paul Grayson, president and CEO of Fate Therapeutics.  "With the strong support of our Scientific Founders and academic and industry collaborators, we are committed to the reliable and efficient generation and differentiation of iPSCs for drug discovery and therapeutic development and leading the identification of small molecules and biologics that can modulate cell fate to develop innovative medicines."

Fate Therapeutics utilizes the most advanced proprietary reprogramming and differentiation technologies for generating cell types of interest to elucidate disease biology and identify targets for therapeutic intervention. The Company's intellectual property portfolio includes exclusive licenses from the Whitehead Institute for Biomedical Research for foundational induced pluripotent stem cell (iPSC) technology invented by Dr. Rudolf Jaenisch and from The Scripps Research Institute for the protein and small molecule reprogramming breakthroughs of Dr. Sheng Ding.  The protein-based reprogramming breakthrough was honored as the Top Technology of 2009 by The Scientist, and the Company's iPSC technology received the 2009 North American Technology Innovation Award from Frost & Sullivan.


'/>"/>
SOURCE Fate Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Amsterdam Molecular Therapeutics Reports Full Year Results 2009
2. Ocera Therapeutics Completes Phase 2B Enrollment in the ASTUTE Trial
3. Cornerstone Therapeutics to Host Fourth Quarter and Full-Year 2009 Conference Call
4. 3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics
5. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2009 Financial Results Before Market Open on Tuesday, February 16, 2010
6. Amicus Therapeutics Board of Directors Names Chief Executive Officer John F. Crowley Chairman of the Board
7. Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference
8. Aegera Therapeutics Initiates a Randomized Phase 2 Study with AEG35156 for the Treatment of Hepatocellular Carcinoma
9. Oxygen Biotherapeutics, Inc. Outlines Plans for New Products During Investor Conference Presentation
10. The Honorable Tommy G. Thompson Joins the United Therapeutics Corporation Board of Directors
11. Cell Therapeutics Commits to PhRMAs Code on Interactions With Healthcare Professionals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... MINNETONKA, Minn. , June 3, 2015 ... company that supports the entire spectrum of clinical research, ... its iMedNet eClinical technology platform ... customers by the end of this month.  iMedNet ... system – built from the ground up by MedNet ...
(Date:6/3/2015)... , June 3, 2015 ... a specialty biopharmaceutical company focused on allergy, today announces ... novel immunotherapy candidates targeting house dust mite, grass and ... Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting ... 6-10 June. Sunday, 7 June 2015 ,Oral ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 Photo-Eyewear™ ( ... its name to PogoTec™, Inc. ( http://www.PogoTec.com ) ... electronic wearable device products and technologies it is developing ... of three business divisions, PogoTec™ will provide focused resources ... as follows: , , On-Track™ – ...
(Date:6/3/2015)... Global Stem Cells Group and its ... conduct Romania’s first ever stem cells harvesting and reintegration ... Stem Cell Training, Inc., Cosmetic Surgeon Morad Iancu, ... Stem Cell Training Course for medical professionals in Bucharest. ... in Bucharest and Tel Aviv, Israel, and a popular ...
Breaking Biology Technology:MedNet Announces "2015 Feature 1" Release Of iMedNet eClinical 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 2Circassia to Present at EAACI Annual Meeting, Barcelona, Spain, 6-10 June 2015 3Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 2Photo-Eyewear™ Changes Name to PogoTec™ and Announces Three Divisions 3Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 2Global Stem Cells Group Announces First Stem Cell Training Course to Take Place in Romania 3
... deCODE genetics,Inc. (Nasdaq: DCGN ) today announced that ... press release to be issued on Thursday, May 1,after the ... host a live,webcast of its conference call to discuss these ... Eastern Time/12 noon GMT/1pm,British Summer Time., The webcast can ...
... Schering-Plough,Corporation announced today that Chairman and CEO Fred ... or 110, 000 shares at,an average purchase price of ... announced my intention to purchase these shares in,January, this ... its products -- including ZETIA and VYTORIN --,and our ...
... Board of,Directors of Shire plc (LSE: SHP) (NASDAQ: ... today that Michael Rosenblatt M.D.,will join the Board ... Dr Rosenblatt is the Dean of Tufts University ... of Medicine at Harvard,Medical School and has served ...
Cached Biology Technology:deCODE genetics Announces Webcast of Conference Call to Discuss First Quarter 2008 Financial Results 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 2Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 3Dr Michael Rosenblatt Appointed Non-Executive Director at Shire 4
(Date:5/19/2015)... , May 19, 2015 ... has announced the addition of the  "Genetic ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent ... an in-depth analysis of the current and ... of gene-based tests, their working principles and ...
(Date:5/14/2015)... Research and Markets ( http://www.researchandmarkets.com/research/5whpxg/fingerprint ) ... Market in Smart Mobile Devices " report to ... was a watershed year for fingerprint sensors in smartphones ... Apple gave fingerprint sensors a raison d,etre in the ... are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... 11, 2015  Synaptics Incorporated (NASDAQ: SYNA ... today announced the appointment of Wajid Ali ... Officer, reporting to Rick Bergman , President ... Financial Officer, Kathleen Bayless , who announced ... Mr. Ali brings extensive financial management expertise to ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2
... new systematic assessment of malnutrition, created by researchers at ... providers in diagnosis and treatment. Up to 50 ... estimated to be malnourished, according to Gordon Jensen, professor ... is widespread, confusion exists in the clinical community on ...
... society to reflect it, says Case Western Reserve University,s ... of thinking about reversing the tide of climate change. ... emissions, changing light bulbs or even developing new technologies ... climate change is societal, born of civic protest against ...
... New findings presented at Europe,s leading breast cancer translational ... many biological differences between individual breast cancers. ... or less sensitive to important therapies, the new studies ... appropriate treatment for millions of patients. "Despite major ...
Cached Biology News:Researchers unveil new assessment for diagnosing malnutrition 2'Ethical Adaptation to Climate Change' envisions the good life in a harsher world 2'Ethical Adaptation to Climate Change' envisions the good life in a harsher world 3New data improve understanding of breast cancer's multiple varieties 2New data improve understanding of breast cancer's multiple varieties 3New data improve understanding of breast cancer's multiple varieties 4New data improve understanding of breast cancer's multiple varieties 5New data improve understanding of breast cancer's multiple varieties 6